These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6344504)

  • 1. [Therapy of reflux esophagitis with antacids].
    Weihrauch TR
    Z Gastroenterol; 1983 Mar; 21 Suppl():50-2. PubMed ID: 6344504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of reflux esophagitis with H2-blockers, antacids and prokinetic drugs. An analysis of randomized clinical trials.
    Koelz HR
    Scand J Gastroenterol Suppl; 1989; 156():25-36. PubMed ID: 2568015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cimetidine versus antacid in scleroderma with reflux esophagitis. A randomized double-blind controlled study.
    Petrokubi RJ; Jeffries GH
    Gastroenterology; 1979 Oct; 77(4 Pt 1):691-5. PubMed ID: 381093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind controlled trial of bethanechol and antacid versus placebo and antacid in the treatment of erosive esophagitis.
    Saco LS; Orlando RC; Levinson SL; Bozymski EM; Jones JD; Frakes JT
    Gastroenterology; 1982 Jun; 82(6):1369-73. PubMed ID: 7040158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopically controlled trial of alginate and antacid in reflux oesophagitis.
    Scobie BA
    Med J Aust; 1976 Apr; 1(17):627-8. PubMed ID: 778564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Peptic esophagitis, complication of gastro-esophageal reflux. A new treatment: Gaviscon].
    Monin E; Chevrel B
    Med Chir Dig; 1975; 4 suppl 2():67-71. PubMed ID: 1219249
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical studies of sucralfate in reflux esophagitis. The European experience.
    Hameeteman W
    J Clin Gastroenterol; 1991; 13 Suppl 2():S16-20. PubMed ID: 1885899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind comparison of liquid antacid and placebo in the treatment of symptomatic reflux esophagitis.
    Graham DY; Patterson DJ
    Dig Dis Sci; 1983 Jun; 28(6):559-63. PubMed ID: 6345111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why do apparently healthy people use antacid tablets?
    Graham DY; Smith JL; Patterson DJ
    Am J Gastroenterol; 1983 May; 78(5):257-60. PubMed ID: 6846300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of Algicon, an antacid-alginate preparation, in patients with reflux oesophagitis.
    Maxton DG; Miller JP; Whorwell PJ; Butler JK
    Br J Clin Pract; 1988 Sep; 42(9):368-71. PubMed ID: 3075928
    [No Abstract]   [Full Text] [Related]  

  • 11. Does dimethicone increase the efficacy of antacids in the treatment of reflux oesophagitis?
    Ogilvie AL; Atkinson M
    J R Soc Med; 1986 Oct; 79(10):584-7. PubMed ID: 3537288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Reflux esophagitis. Comparative clinical, endoscopic and electromanometric study during treatment with antacids and trithiozine].
    Lobello R; Triggiani E; Marzano LA; Magnifico G; Corcione F; Liguori G
    Minerva Chir; 1982 Mar; 37(5):367-8. PubMed ID: 7088332
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of Algicon and ranitidine in the therapy of reflux oesophagitis: preliminary results.
    Pace F; Sangaletti O; Bianchi Porro G
    Br J Clin Pract Suppl; 1989 Feb; 66():59-60; discussion 61-4. PubMed ID: 2511924
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical use of antacids.
    Halter F
    J Physiol Pharmacol; 1993 Sep; 44(3 Suppl 1):61-74. PubMed ID: 8260736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current concepts in the pathogenesis and treatment of reflux esophagitis.
    Frazier JL; Fendler KJ
    Clin Pharm; 1983; 2(6):546-57. PubMed ID: 6360495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of antacids in ulcer therapy. Continuing the tradition or scientific progress?].
    Szelenyi I
    Leber Magen Darm; 1987 Jul; 17(3):150-62. PubMed ID: 3613813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cisapride versus ranitidine in reflux esophagitis].
    Janisch HD
    Z Gastroenterol; 1990 Apr; 28 Suppl 1():67-9; discussion 77-8. PubMed ID: 2192508
    [No Abstract]   [Full Text] [Related]  

  • 19. Controlled trial of a new dosage form of carbenoxolone (Pyrogastrone) in the treatment of reflux esophagitis.
    Reed PI; Davies WA
    Am J Dig Dis; 1978 Feb; 23(2):161-5. PubMed ID: 341689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of reflux esophagitis. Effectiveness of a preparation with an alginic acid base].
    Rigo GP; Perini M; Gandolfo M; Antonioli A
    Minerva Dietol Gastroenterol; 1979; 25(2):163-6. PubMed ID: 471297
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.